TJ-100

Showa Inan General Hospital · Phase 1 active Small molecule Quality 0/100

At a glance

Generic name	TJ-100
Sponsor	Showa Inan General Hospital
Modality	Small molecule
Phase	Phase 1

Approved indications

No approved indications tracked.

Common side effects

No common side effects on file.

Key clinical trials

Hematocrit Effect on a Blood Glucose Monitor (NA)
System Accuracy of the Blood Glucose Monitor for Personal Use JT100 (NA)
Daikenchuto for Intestinal Dysmotility and Prevention of Postoperative Paralytic Ielus After Pancreaticoduodenectomy (PHASE2)
Efficacy and Safety of TJ-100 in the Treatment of Chronic Constipation (NA)

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

Source	Used for
ClinicalTrials.gov	Trial enrolment, design, endpoints, results

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:

TJ-100 CI brief — competitive landscape report
TJ-100 updates RSS · CI watch RSS
Showa Inan General Hospital portfolio CI